Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/8/17 16:40 | 9/6/17 | SCMP | Health | Drug | Pharmaceutical Preparations | Meyenburg Jason Patrick | MD | O | Chief Co | P | 49 | 12.13 | 0 | 4 | 15 | 30 | D | ||||||||||||||
8/7/17 16:35 | 8/4/17 | SCMP | Health | Drug | Pharmaceutical Preparations | Bryan Jones W. | MD | O | Sr. Vice | P | 50 | 10.60 | 0 | 5 | New | 5 | D | ||||||||||||||
11/18/15 16:01 | 11/16/15 | SCMP | Health | Drug | Pharmaceutical Preparations | Smith Andrew P | MD | O | CFO | P | 27 | 17.03 | 15 | 2 | New | 2 | D | 152 | 46 | 6 | -38 | -12 | -17 | -3 | -4 | -3 | -1 | -2 | -28 | -39 | -11 |
6/5/13 15:43 | 5/15/13 | SCMP | Health | Drug | Pharmaceutical Preparations | Maudlin Timothy I | MD | D | P.d | 323 | 9.82 | 3 | 33 | New | 33 | D | 87 | 9 | 53 | 56 | -5 | -20 | -10 | -9 | -5 | -10 | -17 | -26 | -9 | -10 | |
9/8/09 11:36 | 9/2/09 | SCMP | Health | Drug | Pharmaceutical Preparations | Celeste Anthony C. | MD | D | P.m | 25 | 5.02 | 0 | 5 | New | 5 | 25 | 9 | 14 | -22 | -21 | -28 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |